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Reactions to spousal bereavement are very individualized; while a large majority of individuals 
are able to navigate their way through the bereavement process, there are a significant number 
who can’t. Individuals who suffer from complicated grief are thought to be essentially stuck in a 
chronic and intense state of mourning that lasts longer than six months post loss. As one would 
expect, adverse health outcomes are a consequence of untreated complicated grief. It is the 
purpose of this paper to present the reader with evidence that there are effective treatment 
interventions for complicated grief. Additionally, a second purpose of this paper is to create a 
pamphlet to be used by clinicians in a variety of health care settings. This pamphlet will provide 
evidence based research on recognition of complicated grief, risk factors, and effective treatment 
interventions. The pamphlet will enhance clinicians’ awareness of complicated grief, provide 
treatment options and will reduce the increased morbidity and mortality rates associated with 
untreated complicated grief.
Key Words: complicated grief, bereavement, treatment, and pamphlet.
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Recognition and Treatment Modalities for Complicated Grief in the Bereaving Widowed Elderly
According to the U.S. Census Bureau (n.d.), by the year 2030 the numbers of individuals 
over the age of 65 will more than double to 80 million. This will make every one in five 
individuals elderly, making it the fastest growing population. Within this population of 
individuals, dealing with the death of a loved one is nearly inevitable. It is estimated that nearly 
800,000 individuals suffer the loss of a spouse each year (Hensley, Slonimski, Uhlenhuth, & 
Clayton, 2008). Spousal bereavement is considered one of the most stressful life events that an 
individual encounters.
Reactions to bereavement can vary from individual to individual and can include feelings 
of sadness, shock, hallucinations, irritability and numbness (Rozenzweig, Prigerson, Miller & 
Reynolds, 1997) to mention a few. While many who suffer the loss of a spouse are able to 
navigate their way through the grieving process and do so without formal treatment, there is a 
“significant minority where grief is complicated by rumination or excessive avoidance that 
derails the progress of grief’ (Zisook, Simon, Reynolds, Pies, Lebowitz, Young, Madowitz & 
Shear, 2010, p. 1097). This is also known as complicated grief (CG).
When looking at what distinguishes “normal bereavement” from CG, it is said that CG 
has distinguishable features that are quite different than those of bereavement. In an article by 
Shear, Frank, Houck and Reynolds III (2005), an excellent description of the key features 
associated with CG were found: (1) a sense or feeling of disbelief regarding the death; (2) 
feelings of anger and bitterness towards the death; (3) intense yearning and longing for the 
deceased with recurring painful emotions associated with the deceased; and (4) preoccupation 
with thoughts of the deceased and intrusive thoughts related to the death. It is noted that many of 
the features of CG are present in individuals who are displaying a “normal bereavement pattern”
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but these features diminish over time and acceptance of the death increases (Zhang, El-Jawahri, 
& Prigerson, 2006). In individuals who suffer from CG, the bereavement pattern is maladaptive; 
they become stuck in a constant state of mourning (Zhang et al., 2006).
Currently a diagnosis for CG does not exist in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) IV. However, it is being considered and under review for the 
publication of the DSM V. Literature suggests that features of CG are significantly different 
from disorders that are commonly misdiagnosed in bereaving individuals. Post-traumatic stress 
disorder (PTSD), anxiety, major depression disorder and bereavement related depression are 
often the diagnoses that bereaved individuals receive from their providers. This poses a problem 
in that treatment for each of these disorders varies, as does the efficacy of the treatment. The 
lack of a diagnosis has led to underdiagnosing and lack of knowledge on efficacious treatment 
options as well as increased mortality rates.
According to Zisook et al. (2010), there is sufficient evidence that individuals who suffer 
from CG symptoms need treatment interventions and that without treatment, the grief can 
become disabling. Further, literature states that morbidity and mortality rates increase after 
individuals lose their spouses, especially among the elderly. The elderly are a particularly 
vulnerable population in that the majority have underlying medical issues that are often 
compromised by the process of aging, which can further hasten the effects of the grieving 
process.
As clinicians, it will be imperative that one is able to recognize signs and symptoms of 
CG as well as having the ability to incorporate knowledge of effective treatment modalities in 
efforts to curtail adverse health conditions that can result from the loss of one’s spouse.
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Purpose
This independent study will review the literature as it pertains to elderly individuals who 
have suffered the loss of their spouses, in efforts to be able to recognize signs and symptoms that 
are specific to CG, as well as effective treatment modalities for CG. The literature review will 
also include both pharmacological and nonpharmacological interventions that have been utilized 
in treating CG. The clinical question to be answered is, “Are there effective treatment modalities 
for elderly individuals who suffer from complicated grief’?
Upon completion of this literature review, an educational pamphlet will be created for 
health care providers to use in clinical settings to discuss the research findings on recognition 
and treatment of CG. The information in this pamphlet will be written in such a way that 
average patients would be able to read with ease. The pamphlet will include the signs and 
symptoms and effective treatments, as well as community resources that are available for 
widowed elderly with CG. The pamphlet will be used for educating future patients as well as 
health care providers and colleagues.
Significance
Approximately 2.5 million people die each year in the United States. Research suggests 
that this leaves approximately five people for every death to mourn. Given these statistics, it is 
estimated that more than 1 million of these people are expected to develop CG (Shear et al., 
2005). It is known that individuals who suffer from untreated CG are at a heightened risk for 
developing negative health consequences, or even death. What further complicates this is the 
fact that many providers are unsure of how to identify and properly treat patients who may be 
suffering from CG. It has been suggested that the reason for this is that CG is not a diagnosis in
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the DSM IV. The DSM V is currently being rewritten and the inclusion of CG is under 
consideration once again.
Nursing science and nursing practice delivers care through a holistic perspective. 
Nursing recognizes that each individual is unique, as well as complex. The holistic perspective 
encompasses the biological, psychological, social and spiritual aspects of each person (Hamric, 
Spross, & Hanson, 2009). Additionally, each of these pieces interacts with the other throughout 
one’s lifetime. This study has the ability to impact nursing science and practice by providing a 
pamphlet based on the literature reviewed in this study. The pamphlet could serve as a valuable 
resource for a variety of health care providers by assisting them in identifying CG, as well as 
guiding them in setting up individualized treatment plans tailored to their patients. Both 
pharmacological and non-pharmacological treatments have been listed within the pamphlet and 
have been shown to be effective in treating CG, as well as community resources that are 
available. By enhancing knowledge, health care providers will have the ability to recognize an 
abnormal bereavement pattern such as one seen in CG. Further, by identifying and treating 
individuals with CG, morbidity and mortality rates may be reduced.
Theoretical Framework
Lenz, Pugh, Milligan, Gift and Suppe’s Theory of Unpleasant Symptoms will be used as 
the theoretical framework to guide the research gained in this paper, as well as to develop a 
pamphlet that can be used by clinicians in a variety of health care settings. Lenz et al.’s theory 
of unpleasant symptoms “...was based on the premise that there are commonalities in 
experiencing different symptoms among different groups and in different situations” (McEwen 
& Wills, 2011, p. 286). Lenz et al. (1997) discusses the three major components to the theory:
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the symptoms that the individual is experiencing, influencing factors that can either produce or 
affect the symptom experience, and the consequences of the symptom experience.
The symptoms that an individual experiences are the central focus of the model. It is 
stated that individuals can experience multiple symptoms that are likely to catalyze each other, 
which can further be applied to the symptoms associated with CG. Lenz et al. (1997) further 
stated that each symptom is thought to be a multidimensional experience, and that symptoms can 
be common across clinical populations. The model used by Lenz et al. describes how 
psychological, physiological, and situational factors intertwine with the various symptoms 
associated with the illness and therefore influence to outcome experienced by the individual.
Individuals who suffer from CG are in need of effective treatment that is targeted towards 
alleviating their symptoms and curtailing the ill effects it may have on their overall health status. 
The intention of this paper is to provide information to develop a pamphlet that will create 
awareness and enhance knowledge on CG. This pamphlet will serve as a resource for nursing 
staff, clinicians and patients to have the ability recognize if an individual is suffering from CG 
and to provide effective treatment interventions that will decrease symptoms and thereby reduce 
the morbidity and mortality rates associated with untreated CG.
Definitions
There are several terms that require definition and clarification of efforts to provide a 
sound understanding of the concepts presented. These terms include bereavement, mourning, 
and grief.
1) Bereavement: “...refers to the period after loss during which grief and mourning 
occur” (Buglass, 2010, p. 44).
2) Mourning: “...is the outward and active expression of grief’ (Buglass, 2010, p. 44).
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3) Grief: According to Greenstreet (2004) as cited by Buglass, (2010) “Grief describes 
an individual’s personal response to loss and has emotional, physical, behavioral, 
cognitive, social and spiritual dimensions” (p. 44).
Process
The author searched a variety of databases which included CINAHL, PubMed, Scopus, 
Cochrane, and PsychINFO. Searches were conducted utilizing PubMed and PsychINFO as their 
“...content is related to psychology and medicine” which specifically addressed the author’s 
clinical question (Fink, 2010, p. 19).
The search initially began with PubMed and included search terms of “bereavement”, 
“complicated grief’, “elderly”, “aged”, “treatment”, “therapy”, “antidepressants”, and “grief’. 
The author also utilized specific drug names such as “citalopram”, “escitalopram”, “Prozac”, etc. 
The author then reviewed Medical Subject Headings (MeSH) terms to determine the most 
appropriate search related to the clinical question above. The most appropriate search of MeSH 
terms were “bereavement” and “aged” which yielded 1589 articles. This was further limited 
with the search term “therapy” which yielded 41 articles. The author was able to discern 
whether the article was appropriate to the clinical question by the title of the article and/or by 
reading the abstract. The author then “mined” articles with hopes of obtaining further studies 
and references
Scopus was also utilized when “recurring” authors were present. This provided a search 
that was based upon a specific author. Recurring authors that were searched were Zisook, Shear 
and Hensley. The mentioned authors have done extensive research on bereavement related
disorders.
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The search was further explored by using PsychINFO database to find correlations in 
regards to ill health and untimely death. Search terms that were utilized included DE 
“Bereavement” OR DE “Grief' and Epidemiology. This search resulted in 118 articles where 
the author was able to decipher the relevance to the clinical question, “Are there effective 
treatment modalities for elderly individuals who suffer from complicated grief?” by either the 
title of the article or the abstract and was able to narrow this number. A total of fifteen articles 
were included in this review.
The information taken from this literature search will be used to develop a pamphlet for 
clinicians in a variety of health care settings that will enhance recognition of CG, risk factors as 
well as effective treatment interventions to be used. The pamphlet will be critiqued and 
evaluated by the author’s mentors in practice, as well as fellow colleagues and course instructors. 
Revisions will be made based upon recommendations and the pamphlet will then be presented to 
the author’s mentors in practice. Copies will be provided to them to dispense or utilize at their 
discretion.
Review of the Literature
The literature found regarding CG has proved there are efficacious treatment modalities 
used to diminish symptoms associated with a pathological bereavement pattern. Given the 
significant consequences surrounding untreated CG in the elderly, there is a need for effective 
treatment interventions. By providing education on efficacious treatments, morbidity and 
mortality rates may decrease. Research shows that individuals who suffer from CG are at 
increased risk for developing cancers, cardiac events, hypertension, ineffective coping with 
increased tobacco and/or alcohol consumption, and suicide. Enhancing awareness by providing
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an educational pamphlet to be utilized in various health care settings would provide recognition 
and treatment options for those whom suffer from CG.
The following review and critique will examine six clinical trials conducted by Hensley, 
et al. (2008), Zygmont, Prigerson, Houck, Miller, Shear, Jacobs, & Reynolds III (1998), 
Pasternak, Reynolds III, Schlemitzauer, Hock. Buysse, Houck, & Perel (1991), Jacobs, Nelson,
& Zisook (1987), Zisook, Shuchter, Peclrelli, Sable & Deaciuc (2001), and Boelen, Keijser, Van 
den Hout & Van den Bout (2007); six randomized control trials by Cruz, Scott, Houck. Reynolds 
III, Frank & Shear (2007), Wagner, Knaevelsrud, & Maercker (2006), Wagner, Knaevelsrud, & 
Maercker (2007), Shear, Frank, Houck, & Reynolds III (2005), and Rosner, Lumbeck, & 
Geissner (2011); two meta-analyses conducted by Wittouck, Van Autreve, De Jaegere, Portzky, 
& van Heeringen (2011), and Currier, Neimeyer, & Berman (2008); one cohort sequential study 
conducted by Ott (2003); and one evidence based guideline by Zhang et al. (2006).
The literature reviewed for this study discussed different treatment modalities that have 
been shown to be efficacious in treating CG. The studies presented will be divided into 
pharmacological interventions and non-pharmacological interventions. This will be done in an 
effort to provide a generalized flow to the review of literature.
Evidence thus far, consistently shows that symptoms of complicated grief are diminished 
through the use of antidepressants (Hensley et al., 2008; Pasternak et al., 1991; Zygmont et al., 
1998; Jacobs et al., 1987; & Zisook et al., 2001). While many of these studies are greater than 
ten years old, they should not be disregarded as they are still valuable studies that confirm the 
effectiveness of using antidepressants in treatment of CG.
In a study conducted by Hensley et al. (2008) in Albuquerque New Mexico, the primary 
objective was to evaluate whether treating bereavement-related depression with escitalopram
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demonstrated an improvement in depression ratings following the death of a close family 
member. This study had an open-label design. Subjects in this study had an age range from 
twenty to seventy-six whom had experienced a loss within twelve months. The sample size was 
thirty (n=30). Of this sample, twenty seven of the subjects were female and three were male.
The subjects were classified as either having complicated grief or uncomplicated grief based on 
using the Inventory of Complicated Grief (ICG) scale. Thirty subjects were started on 
escitalopram on their second visit and attended scheduled visits over a period of twelve weeks. 
Outcome measures used the analysis of variance for repeated measures (ANOVA) and it was 
implemented using the Number Cruncher Statistical System.
The findings in this study showed that escitalopram showed improvement in symptoms of 
depression, anxiety as well as grief. Escitalopram was generally well tolerated in this sample 
with few side effects reported. The study included a variety of bereavement losses which further 
generalized the study as well as the ethnic diversity represented in the community in which the 
study took place. Although the results of this study regarding effective treatment in CG are 
promising, there are confounding limitations that one should be aware of.
There are several caveats to this study that should be explored. Given the small sample 
size and short duration of the study, it did not provide an absolute consensus that escitalopram 
should be considered effective in treating CG. It was known that antidepressants can take up to 
three months before a decrease could be seen in depressive symptoms. It should also be noted 
that in this study, participants were able to receive psychotherapy outside of the study which 
could further skew the results. Begging the question, “Did the escitalopram decrease their 
depression symptoms or was it the psychotherapy”? Further, one could argue that a combination 
of these two therapies created the decreased symptoms and that it was not one or the other.
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Pasternak et al. (1991) conducted an open-label clinical trial study to evaluate whether 
bereavement-related depression in later life responds effectively to nortriptyline. This study was 
an open-label clinical trial where a sample of thirteen elderly bereaved depressed adults whom 
were a part of a larger group participating in an investigation of EEG sleep changes that were 
associated with recent spousal bereavement-related depression. The sample age ranges at the 
time of entry were 61 to 78 years old. This included five men and eight women. The average 
timespan from the death of the spouse was 11.9 months, with a range from 2 to 25 months. 
Interestingly, this study added twenty additional subjects that met the inclusion criteria that they 
were non-depressed bereaving adults. Analysis of the sample was measured using the depression 
ratings (HAM-D), the Global Assessment Scale (GAS), the Beck Depression Inventory (BDI), 
the Texas Revised Inventory of Grief (TRIG) the Interpersonal Support Evaluation List (ISEL) 
and the Cumulative Illness Rating Scale (CIRS).
Results of this study showed that there was significant improvement in the bereavement 
related depression symptoms through the use of nortriptyline. Scores of the HAM-D, BDI and 
the Brief Symptom Inventory (BSI) showed improvement of 67.9%, 68.4% and 54.5% 
respectively. Nortriptyline was well tolerated by all thirteen subjects as no one had to discontinue 
use.
In an open-label clinical trial Zygmont et al. (1998) compared the effectiveness of 
treating complicated grief symptoms in adults with paroxetine with an ongoing controlled study 
utilizing nortriptyline and its treatment effects in bereavement related depression by Pasternak et 
al. (1991). A sample of fifteen bereaved volunteers was recruited including ten from media ads, 
and five clinically referred to participate in the study. Their mean age was 56.9 years which 
included eleven women and four men. The losses suffered included eight spousal, five children,
COMPLICATED GRIEF 13
one grandchild, and one parent. The majority of the subjects were Caucasian (14) and one was 
black. Analysis of the scores occurred at baseline and at week sixteen on the fifteen paroxetine 
subjects. A comparison of the changes in scores on the HAM-D and ICG utilized a Spearman's 
rho correlation.
The findings of this study reported that the level of complicated grief symptoms 
decreased 53% in the subjects whom were treated with paroxetine. The depression ratings also 
decreased by 54%. This study concluded that both paroxetine and nortriptyline showed 
comparable results in reducing complicated grief symptoms and depression ratings through the 
use of the ICG and HAM-D.
The two medications that were compared in this study, paroxetine and nortriptyline, are 
antidepressants from different classes; selective serotonin reuptake inhibitor (SSRI) and a 
tricyclic antidepressant (TCA) respectively. This enhances the credibility that antidepressants 
could be utilized as an effective treatment in CG. However, the lack of a control in this study 
and the small sample size are limitations that should be noted. Another limitation is that the 
duration of the study is relatively short and without follow-up. Further research is needed to 
determine the overall effectiveness of using these medications.
Jacobs et al. (1987) conducted a clinical trial in a moderate sized metropolitan area to 
evaluate the effectiveness of desipramine on bereavement related depression. This study 
included a sample size of ten. There were eight widows and two widowers. The subjects' age 
ranged from 36 to 65, all had suffered the loss of their spouse within 1-2 years. Improvement 
was measured by using the Hamilton Depression Rating Scale (HDRS), the Clinical Global 
Impressions (CGI) scale and a Raskin three-area rating of depression. These measurements 
occurred initially as well as at each visit that occurred every one to two weeks.
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After four weeks of treatment with desipramine, 70% had moderate to marked 
improvement of their depressive symptoms. 20% had minimal improvement. This study was 
very short in duration, a total of four weeks. After the four weeks of treatment, the subjects were 
referred back to their primary provider without follow-up within the study. This was a major 
limitation to the study. Further, the sample size of the study was small and lacked a control 
group.
Another study regarding pharmacological interventions was conducted by Zisook et al. 
(2001). This study was an open-label clinical trial based out of San Diego County that set out to 
evaluate whether bereavement responds effectively to bupropion sustained release. The sample 
of twenty-two subjects whose ages ranged from 45 to 83 years who had all lost their spouses 
within the previous six to eight weeks. There were 17 females and five males. Ethnicity was 
reported as 19 Caucasian, two Hispanic and one African American. Improvement was measured 
by using the HAM-D, CGI scale, TRIG, and ICG.
Assessments occurred during the initial assessment and at follow-up approximately eight 
weeks later. Out of the initial sample of 22, there were 14 subjects that completed the study.
The initial sample as well as the completer sample showed statistically significant improvement 
on the HAM-D and CGI scale. Findings of this study showed there was moderate improvement 
in the grief score and that the depression score showed significant improvement.
Strengths associated with this study were that this study supported literature where SSRIs 
and tricyclic antidepressants were effective in treating bereavement related depression. Further, 
bupropion use in the elderly is safe and has minimal side effects. However, the lack of a control 
group is a major limitation as well as the small sample size. Another caveat is that the inclusion 
to this study required the loss of the subjects’ spouses during the previous six to eight weeks and
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the duration of the study only occurred over four months. Normal bereavement patterns 
typically improve over the first six months. Abnormal bereavement patterns, such as those 
considered in complicated grief generally aren’t assessed until three to six months post loss.
The antidepressants that were studied included escitalopram, nortriptyline, bupropion 
sustained release, desipramine, and paroxetine. There has not been a study to date, that this 
author is aware of, that recommends one antidepressant over the other for use in elderly 
bereaving adults. Further, many of these studies were conducted in the 1980s and 1990s, 
indicating the need for more current research.
Literature suggests that antidepressants could be considered effective in treating 
bereavement related depression and may reduce symptoms of complicated grief. There is a need 
for larger studies as well as ones with a control group. Many of the studies suggest there is an 
ethical dilemma of including a control group when using pharmaceuticals; the dilemma 
specifically relates to not treating a group who is suffering from CG.
When looking at nonpharmacological treatment options, literature consistently shows that 
various forms of Cognitive Behavioral Therapy (CBT) produces a reduction in CG symptoms 
and overall severity of CG. Studies further suggest that therapy targeted specifically towards 
bereavement has been shown to be more efficacious over more generalized forms of therapy.
A clinical trial conducted by Boelen et al. (2007) compared the effectiveness of CBT 
with a nonspecific treatment through supportive counseling in treating CG. The sample was 
taken from seven outpatient clinics located in the Netherlands. Of this sample, 14 were male and 
40 were female (n=54). The types of loss suffered by the subjects ranged from loss of a 
spouse/partner (n=15), a child (n= 12), a parent (n=15) and other losses (n=12). Each of the
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subjects was recruited through various referral sources which ranged from self or professional as 
well as through advertisements in newspapers and the internet.
Inclusion criteria set forth by Boelen et al. (2007) were such that the subject must have 
experienced a loss greater than two months ago with a score of at least 25 on the ICG. 
Additionally, CG was to be their primary problem and reason for seeking therapy. Individuals 
were excluded from the study if there was current substance abuse/dependence, psychotic 
symptoms, risk of suicide, severe depression, or those currently receiving other psychotherapy.
Individuals were allocated to three groups through minimization. The first group (n=23) 
received cognitive restructuring (CR) with an addition of exposure therapy (ET). The second 
group (n=20) received ET with CR added later during therapy. The third group (n=l 1) received 
supportive counseling (n=l 1). Each subject was measured at three separate intervals which 
included pre-treatment, mid-treatment, and post-treatment by using a multivariate analysis of 
variance (MANOVA). An analysis of variance for repeated measures (ANOVA) was conducted 
following the three measurement intervals on the outcome measures. The treatment effect sizes 
(ESs) were calculated using Cohen’s d statistic.
The results of the study concluded that the ES was greatest for the first group who 
received ET for the first six sessions. ESs from mid-treatment to post-treatment showed that 
adding ET to CR produced an additional effect over adding CR to ET. Overall, this study 
concluded that CBT conditions that included CR and ET were more effective than SC alone. 
Given that this study utilized therapy that targeted symptoms of CG and compared it to a control 
group who didn’t receive such treatment; it further solidifies the efficacy of using a CBT 
approach. The effectiveness of ET with CR is comparable to a study conducted by Shear et al.
(2005).
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Shear et al. (2005) conducted a randomized controlled trial that set out to compare the 
effectiveness of treating CG through interpersonal psychotherapy (IPT) and complicated grief 
treatment (CGT). The sample from this study was taken from a university-based psychiatric 
research clinic as well as from a low-income African American community. The subjects were 
recruited through professional referral, self-referral, and media advertisement, which was very 
comparable to how Boelen et al. (2007) recruited their sample. Further, both of these studies 
used the same assessment tool, the ICG.
Shear et al. (2005) discussed the inclusions which were a score of greater than or equal to 
30 on the ICG and the loss suffered must have occurred at least six months prior to the study. If 
subjects were utilizing antidepressants, they had to be at a stable dose for a minimum of three 
months. Subjects who were current substance abusers or had a history of dependence within the 
past three months were excluded as well as those with a history of psychotic disorders, bipolar 
disorder, and suicidal ideation requiring hospitalization, those with concurrent use of 
psychotherapy, and those who have a pending lawsuit related to the death.
The sample (n=95) included 83 women and 12 men who’s ages ranged from 18 to 85 
years old. The participants were assigned randomly to one of two groups. The first group was 
the CGT group (n=49) and the second group was the IPT group (n=46). The demographics of 
the sample were distributed in a fairly even manner between the two groups, as were the types of 
losses suffered. The relationships to the deceased included a spouse/partner, parent, child, and 
other which are comparable to the study conducted by Boelen et al. (2007).
Conchran-Mantel-Haenszel general association analyses were used to compare the 
responder rates for the two groups and Kaplan-Meier curves were used to explore the time to 
response. SAS software, version 8.2 was used for all of the analyses. The mean number of IPT
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and CGT sessions was 16 and the mean time to complete the sessions was 18.4 weeks and 19.4 
weeks respectively.
This study showed better response to CGT versus IPT, however both showed positive 
responses. Within this study, subjects who were taking stable doses of antidepressants had 
marginally better response rates versus those who were not taking antidepressants. 
Unfortunately, this study does not specifically address which antidepressants the subjects were 
taking. Given that there were better response rates with concomitant use of both 
pharmacological and nonpharmacological treatment, perhaps this could be a better treatment 
option. At this time, further research is needed to validate its effectiveness.
A study conducted by Cruz et al. (2007) further explored the aforementioned study 
conducted by Shear et al. (2005) through a secondary analysis. The aim of the study was to 
distinguish whether ethnicity played a role in the presentation symptoms of CG or in their 
treatment outcomes.
The sample for this study was derived from Shear et al. (2005) that including nineteen 
African Americans and nineteen Caucasian Americans; all of which had CG. The subjects were 
randomly assigned to receive IPT or CGT. Since this was a secondary analysis of a previous 
study, the inclusion and exclusion criteria remained the same, as did the treatment and analyses.
The results of the study showed that the African-American and Caucasian-American 
participants demonstrated no differences in the pre-treatment severity of symptoms or in 
treatment engagement or response. Further, the authors of this study concluded that one should 
not expect to see a difference in clinical presentation of CG or in the response to treatment based 
on one’s ethnicity; specifically comparing African Americans and Caucasian Americans.
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Given that the sample size was quite small, and only two ethnic groups were compared, 
this was a considerably vague generalization to make. The study would have more credibility in 
regards to ethnicity if multiple cultural differences were taken into consideration. This study 
does however provide insight; it gives way to another avenue that needs further exploration 
given that the majority of the studies thus far are predominantly Caucasian participants.
Wagner et al. (2006) explored an alternative to the typical face-to-face CBT; they 
conducted a randomized controlled trial to determine whether an internet-based CBT approach 
would benefit individuals who suffered from CG. The sample was recruited through 
advertisements and links that were posted on psychology websites, websites of organizations of 
bereaved persons, as well as announcements in print media. This study involved participants 
who were fluent in German.
Participants in this study met the inclusion criteria: symptoms of intrusion, avoidance and 
maladaptive behavior which were caused by the loss of someone significant in their life. 
Applicants were excluded if they were receiving concurrent therapy elsewhere, substance abuse, 
younger than 18 years of age, severely depressed or having suicidal ideation, at risk of psychosis, 
dissociative tendency, not fluent in German or if the participants loss was less than fourteen 
months ago.
The sample of 55 participants whose ages ranged from 19 to 68 years old were randomly 
assigned to two groups; the treatment group (n=29) or the waiting condition group (n=26). The 
types of losses suffered in this study were consistent with previous studies such as partner, 
parent, child, friend, or relative (Boelen et al., 2007; Shear et al., 2005; & Cruz et al., 2007). The 
type of loss in this study however was predominantly the loss of a child.
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The design of this study included the treatment group and waiting condition as well as the 
effect on pre-treatment as opposed to post-treatment. Various scales were utilized to measure the 
participants’ symptoms of CG and measure improvement of these scores; the BSI for anxiety and 
depression, the Impact Event Scale (IES), and a failure to adapt scale. MANOVAs and ANOVAs 
were used to test for interaction effects between the two groups. The differences in scores from 
pre-treatment and post-treatment between the groups were analyzed and effect sizes were 
calculated using Cohen’s d for repeated measures.
The results of this study showed very large effect sizes at post-treatment and at the three 
month follow-up in regards to CG symptoms. Further, this study concluded that the internet- 
based treatment led to significant reductions in CG symptoms such as intrusion, avoidance, and 
maladaptive behaviors. It was also reported that participants had a reduction in depression and 
anxiety.
Interestingly, 83% of the participants in this study reported they felt the contact between 
themselves and the therapist was “personal” and 85% felt it was “pleasant” to communicate with 
the therapist exclusively through email. Only 20% felt as though they “missed the face-to-face 
contact” with the therapist. Perhaps the stigma of “ineffective coping” lends favor to individuals 
who may otherwise forgo treatment in fear of being labeled. The anonymity may be appealing to 
such individuals, including those who have incorporated the technology of the internet into their 
life.
An explorative study conducted by Wagner et al. (2007) sought to further explore the 
effects of the internet-based CBT intervention in CG (Wagner et al., 2006) on post-traumatic 
growth and optimism and whether the improvement in symptoms was due to the increase in post-
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traumatic growth or optimism. The inclusion and exclusion criteria, participant demographics 
and relationship to the deceased are described in the previous study (Wagner et al. 2006).
Measurements of this study were assessed at pre-treatment, post-treatment, three month 
and fifteen month follow-up. Participants were assessed by self-report utilizing various 
assessment tools. The Post-Traumatic Growth Inventory (PTGI) was revised to a short form 
(PTGI-SF) to assess perceived outcomes based on personal strength, spiritual change, relating to 
others, appreciation of life, and the outlook of new possibilities. The Life Orientation Test- 
Revised (LOT-R) was utilized to assess the participants’ individual optimism. Again, the effect 
sizes were calculated using Cohen’s d and analyses utilized ANOVAs.
The results of this study indicated that the internet CBT intervention correlated with a 
substantial increase in post-traumatic growth however there wasn’t a correlation in regards to 
increased optimism. Further, this study contributes to previous literature that CBT is an effective 
treatment modality for CG and can enhance post-traumatic growth in individuals.
Each of the studies discussed thus far have explored therapy interventions for CG in an 
outpatient setting. Rosner et al. (2011) were the first to evaluate individuals in an inpatient 
setting. They conducted a randomized controlled trial that set out to evaluate whether inpatients 
with CG benefited from additional CG interventions. This study screened all patients for CG 
who were admitted from January of 2006 to June of 2007. Additionally, this study included 
individuals who had at least one other diagnoses besides CG. The majority of other studies 
excluded such individuals.
The sample included subjects whose ages ranged from 17 to 79. Two groups were 
formed: the complicated grief group (n= 50) and the Treatment as Usual (TAU) group (n=22). 
Participants were placed into the respective groups based upon when they were interviewed and
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provided they met the inclusion criteria. Inclusion criteria set forth included a positive screening 
result for CG, willingness to participate and no acute crisis. Participants who were interviewed 
from January of 2006 to June of 2006 and met the criteria were placed in the TAU group. 
Participants who were interviewed from July of 2006 to June of 2007 and met the criteria were 
placed in the complicated grief group. Between the two groups, age, gender and education did 
not vary.
The treatment interventions varied between the two groups in that the complicated grief 
group utilized CBT that included grief specific protocols, where the TAU group did not include 
the grief specific interventions. It should be noted that both groups received TAU therapy. The 
CG intervention group received nine double sessions twice per week that lasted 4.5 weeks. The 
TAU consisted of one weekly individual therapy session, two weekly group sessions and one or 
two weekly sessions that related specifically to the participant’s primary diagnosis.
The ICG was the primary outcome measurement tool used in this study. Other scales 
were used which included the BDI and the Symptom Checklist-90-Revised (SCL-90-R). These 
were completed at admission and discharge; no follow-up was completed in this study. The 
sums of scores were computed for each participant and ANOVAs were conducted.
Results from this study showed that treatment of CG in inpatient settings is effective and 
that treatment specifically tailored to grief symptoms is more effective. Further, this study 
suggests that it is useful to screen individuals for CG and provide grief-specific interventions for 
inpatients, as well as those with comorbid disorders. Again, this study had a relatively small 
sample size and the unequal group sizes could be considered a limitation to the study. The 
consistency of the scales utilized in assessing CG is beneficial as one is able to make better 
comparisons of other studies that have been conducted.
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In a meta-analysis, Wittouck et al. (2011) sought to determine the short-term and long­
term effects of specific grief interventions utilized for adults. This study included only 
randomized controlled trials that used specific grief interventions to treat or prevent CG. The 
researchers searched electronic databases of Web of Science and Psyc Articles using search terms 
and Boolean operators: “bereave OR mourning OR grief OR survivor OR widow” (p. 70) and 
“psychotherapy OR therapy OR intervention OR treatment OR managing OR counseling OR 
support OR help” (p. 70). The articles that met the inclusion criteria were further mined for 
other eligible studies. Further, only studies that were published between 1990 and 2007 were 
utilized in this study. A total of 14 citations met the inclusion criteria and were included in this 
meta-analysis (n=14).
Wittouck et al. (2011) found through this study that the effectiveness of preventative 
interventions showed inconsistent support; however it is imperative to note that the study did 
show that treatment interventions were effective in both short-term and long-term CG symptoms. 
This study further pointed out that the majority of the participants in the studies analyzed were 
predominantly female. This finding is consistent with the studies noted previously within this 
review of literature. Furthermore, even though there was inconsistent support in the 
effectiveness of preventative interventions, this should not be applied across the board for all 
individuals. If an individual suffering from bereavement seeks treatment, treatment should not 
be withheld as it could be beneficial.
Currier et al. (2008) examined the effectiveness of bereavement interventions in a meta­
analysis they conducted. This review was based on 61 (n=61) outcome studies where only 
controlled studies were used. Of the studies that were included in this review, 48 were published 
peer-reviewed articles and 16 were unpublished dissertations. The comprehensive search was
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done by utilizing PsychINFO, PsycARTICLES, Medline and Dissertation Abstracts International 
using search terms such as bereavement, grief, treatment outcome, intervention, control group 
and evaluation.
The measures of therapeutic outcomes were converted to a Cohen’s d and what resulted 
from this study was that bereavement interventions were shown to be efficacious versus the non­
treatment control groups. Further, the mean effect size at post-treatment in individuals who had 
poor bereavement adaptation was found to be significantly higher than in those studies with a 
universal population. Within universal populations, ones who didn't specifically display CG 
symptoms, the interventions failed to produce sizeable results versus the passage of time.
This study included more studies than the meta-analysis conducted by Wittouck et al.
(2011); however both contributed to the growing body of literature that states psychotherapeutic 
interventions are effective in treating CG. Currier et al. (2008) discussed that interventions 
aren’t always needed in a “normal” bereavement pattern and that interventions didn’t show 
improvement within individuals navigating their way through a “normal” bereavement process. 
Evidence shows that the passage of time is what is needed when CG are not present, furthermore, 
individuals who suffer from CG indeed benefit from therapeutic interventions.
As one would expect, untreated CG can bring about many negative health consequences. 
A study conducted by Ott (2003) sought to determine whether CG caused an increase in mental 
and physical health problems specifically in bereaved spouses. This study was part of a larger 
study conducted by Howard, Lueger, Maling, & Martinovich (1993) in which the results of from 
that analysis were integrated with data retrieved one year later from the current study.
The sample of this study included 120 bereaved spouses who had recent deaths of their 
spouses and had no major “self-reported” mental health diagnoses. The subjects were primarily
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Caucasian, 97%, and ranged in ages from 27 to 87. A cohort sequential design was used and 
subjects were grouped by their bereavement time (3 month intervals), starting at three months 
and continued up until 36 months bereaved. The actual data that was included was over an 18 
month time period. Assessment tools that were utilized included the ICG and the Mental Health 
Inventory (MHI). The ICG was assessed at the beginning of the study and then again at three 
and six months later. The MHI was administered five times; at the beginning of the study and 
then at 2 three month intervals and finally, one year later. Participants were described as those 
with CG and those without complicated grief (NCG) based on their ICG scores.
The CG and NCG groups were analyzed on “...sociodemographic measures, 
participation in professional counseling, and attendance at grief support groups” (Ott, 2003, p. 
256) by using chi square analysis. ANOVA was used to compare the MHI scores during each 
time frame for the two respective groups. A Pearson’s correlation was calculated to assess the 
relationship between the MHI scores and CG status.
Ott (2003) discussed four observations that could be made from the data gained in this 
study: participants in the CG group didn’t vary from the NCG group in regards to 
sociodemographic measures or whether participants engaged in professional counseling or grief 
support groups. The CG group perceived less social support and increased life stressors than 
those in the NCG group. The CG group had lower scores on the MHI and higher current 
symptoms starting six months after the loss of their spouse and remained significantly higher 18 
months post-loss as opposed to those in the NCG group, and there was no significant difference 
in the prevalence of self-reported physical or mental health illnesses between the respective
groups.
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Only one evidence based guideline for diagnosis and treatment for CG was found. Zhang 
et al., (2006) provided a guideline to assist clinicians that discussed the difference between 
normal bereavement patterns as well as patterns associated with CG, differentiating CG from 
other mental disorders that are associated with bereavement, as well as effective bereavement 
interventions. Their primary objective for this update on bereavement was to “...provide 
information to guide clinicians in their evaluations of interventions with bereaved individuals” 
(Zhange et al. 2006, p. 1189).
As Zhange et al. (2006) points out, individuals who met the criteria for CG benefited the 
greatest from bereavement interventions. They further discussed the various types of 
interventions that are listed within this review of literature such as the use of pharmacological 
interventions as well as psychotherapeutic interventions such as CBT and CGT. These 
interventions have been shown to be efficacious in treating bereavement related depression and 
CG symptoms; however it was felt that further research is needed. This is very evident in 
regards to the need for randomized controlled trials and pharmacological interventions.
Discussion
Interpretation
It is not surprising that clinicians are often at a loss on how to effectively help their 
patients during times of bereavement. This is especially true when individuals display 
ineffective bereavement patterns, specifically when they are exhibiting prolonged grief such as 
those who are experiencing CG. Currently, there is no such diagnosis, which further contributes 
to the confusion. CG is now being considered for inclusion in the DSM V which could lend to 
effective treatment interventions. The possibility of CG as a diagnosis in the DSM V has
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brought about increased attention, further research, and updates on what is currently known. 
Essentially, it has now been put “back on the radar".
Bereavement is considered a natural part of one’s life experience and, as one ages, these 
experiences become increasingly more frequent (Zhange et al., 2006). A tendency for clinicians 
to dismiss CG as “normal bereavement” may further compound the increased risk of mortality 
and morbidity associated with CG. Furthermore, there has been conflicting evidence on when to 
assess individuals who appear to be suffering from CG. It is suggested that this diagnosis could 
be made six months post loss and that individuals whom display an abnormal bereavement 
pattern is often seen after the six month timeframe.
The literature reviewed for this paper suggests that there are various treatment modalities 
that are considered effective in managing symptoms associated with CG. Pharmacologically 
speaking, only a handful of medications have been tested thus far in regards to treating CG. 
These medications included escitalopram, paroxetine, nortriptyline, bupropion, and desipramine 
(Hensley et al., 2008; Pasternak et al., 1991; Zygmont et al., 1998; Jacobs et al,. 1987; & Zisook 
et al., 2001). While each of these medications showed benefit in reducing bereavement related 
depression, they weren’t comparisons done with control groups. Research suggests that ethical 
reasons played a role in withholding medication from a group that could benefit from it.
Research suggests that when looking at nonpharmacological interventions, CBT has 
proved to be an effective form of treatment for CG. Many forms of CBT have been studied and 
evidence showed that incorporating grief therapy with CBT has proved to enhance overall scores 
on the ICG of patients with CG. These findings further solidify the assumption that to date, there 
are effective treatment options for CG, but perhaps the ultimate intervention has yet to be
discovered.
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By incorporating Lenz et al.’s theory of unpleasant symptoms to design a pamphlet for 
nurses and clinicians, it allows one to look at how each symptom the individual is experiencing 
has the ability to catalyze other symptoms and therefore contribute to ill effects on one’s health. 
Treating the cluster of symptoms associated with CG through the use of CBT and or 
pharmacological interventions can alleviate the overwhelming burden the individual has 
succumbed to.
Outcome/Dissemination
The information gained in the review of literature was used to create a pamphlet that will 
aid health care providers to use as a resource for elderly widowed individuals suffering from CG 
by enhancing awareness of how to identify CG, effective treatment options, and provide 
community resources available (see Appendix). Once the pamphlet was completed, it was 
disseminated via email to peers and graduate nursing instructors to determine the effectiveness 
and clarity. The pamphlet was also critiqued by the author’s mentors in practice. In total, six 
peers, three instructors, three physicians, one geriatric nurse practitioner and one physician’s 
assistant provided feedback on the pamphlet. Many comments were positive with many 
constructive comments mainly on formatting and word choice for the ease of the reader. The 
comments were compiled and taken into consideration, revisions were made to the pamphlet, and 
professional copies were made for delivery.
The completed pamphlet was presented to the author’s mentors in practice with an 
overwhelmingly positive response. Each of the providers reported that they had very limited 
knowledge in what CG actually is or how to treat it. The common response when asked what 
their thoughts were on CG was that it is when there is a difficult death or “complicated” 
circumstances surrounding the death. Providers felt as though they could recall specific
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individuals they felt would have benefited from therapy which was tailored more towards 
alleviating symptoms, such as those mentioned in the pamphlet. The author’s mentors felt as 
though the pamphlet would be an asset for patients who suffer from CG symptoms, as well as a 
great resource for other health care providers. It was recommended that the pamphlet be 
distributed among the community pastors and priests as they are often providing home visits 
during the bereavement period. Additionally, it was recommended to distribute the pamphlet to 
local funeral homes, as they could include it in their after-care program for bereaved individuals. 
Additional pamphlets will be printed and distributed as recommended.
Implications for Nursing
Practice
It is estimated that nearly 75% of all deaths occur in individuals 65 years and older; 
nearly half of these individuals result in widowed females (Zhange et al., 2006). Recent studies 
have indicated that a lack of a concrete diagnosis in the DSM IV has contributed to under 
diagnosing and a lack of treatment within this population. This could contribute to a lack of 
understanding of what CG is and what differences exist in normal bereaving patterns.
The ICG has proved to be an effective tool to use to identify individuals with CG. For 
individuals who have elevated scores on the ICG, treatment is warranted. It is imperative for 
clinicians to have an evidence based resource, such as a pamphlet, available to assist in providing 
knowledge of CG, risk factors, and symptoms as well as effective treatment options. If 
individuals who suffer from CG are left untreated, they are at a heightened risk of developing 




Clinicians need to be educated on recognition of CG and treatment options that have 
proved to be effective. Clinicians also need to be aware of individuals who are at risk for 
developing CG. Education should include what a “normal” bereavement pattern looks like, as 
well as an “abnormal” bereavement pattern such as seen with CG. It is imperative that clinicians 
are aware that abnormal bereavement patterns are associated with increased morbidity and 
mortality. Further, clinicians should be educated on providing treatment interventions after six 
months post loss for individuals with CG; less than six months could represent a normal 
bereavement pattern that will likely improve with time.
Policy
In the practice setting, policy will need to be developed for individuals who are identified 
as having CG. The pamphlet that was created would provide a useful tool that will aid in 
recognition, risk factors, symptoms and treatment options available. Policy would be needed to 
utilize the pamphlet as an educational tool for clinicians to incorporate within their practice. 
Policy should include follow up for individuals to ensure that the treatment intervention that was 
selected was effective and if not, that a new intervention should be implemented.
Research
This review of literature revealed that there are limited studies in regards to elderly 
bereaved widows with CG. Again, this could be attributed to the lack of a current diagnosis in 
the DSM IV. With the consideration of including CG in the DSM V, CG is currently “back on 
the radar”. The inclusion of CG in the DSM V would likely provide an opportunity and need for
further research.
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Research showed that pharmacological interventions were useful in treating bereavement 
related depression; however the studies each lacked a control group. As it is mentioned earlier in 
this paper, authors of many studies felt as though it would be unethical to withhold treatment to 
those who clearly have a need. Further studies are needed to assess whether or not combined 
treatment could be considered efficacious such as CBT in conjunction with an antidepressant.
A large portion of the research conducted thus far has been predominantly female, it 
would be recommended that research should include or focus on more males. Within the elderly 
population, it is noted that a large majority are female widows which would suggest that perhaps 
this population is accurately assessed. Further research should also include various ethnic 
backgrounds as Caucasians have been the ethnic group predominantly studied.
Summary/Conclusions
After reviewing the literature, it is clear there are effective treatment options available for 
individuals who suffer from CG; however the lack of a concrete diagnosis contributed to under 
diagnosing. CG is associated with adverse effects on one’s health if left untreated. Given that 
nearly 75% of all deaths occur in individuals over the age of 65 and half of these result in 
widowed females, the incidence rates of CG are expected to climb with the baby-boom 
generation. “Estimates suggest each death leaves an average of five people bereaved, suggesting
that more than one million people per year are expected to develop complicated grief in the
.
United States” (Shear et al., 2005).
Literature suggested that the use of CBT and pharmacological options have been shown 
to be effective treatment interventions for CG, further research needs to be done. Clinicians are
often at the forefront in patient care and are looked upon as the ones who “can make it better”.
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t o  b e  e f f e c t iv e  in t r e a t in g  g r e f  
re la te d  d e p r e s s 'c n  as w e ll as 
re d u c in g  s y m p to m s  a s s o c ia te d  w ith  
c o m p lic a t e d  g rie f.
• ]_**»  p r o .  P a m e ic r . \ \  e ilb u tn n , 
N Jc rp ra m m . a n d  P a x il are 
m e d ic a t io n s  s tu d ie d  th u s  fa r.
i he*~ap :̂
• 0 ° £ rrt' -e &eha^ior T h e ra p y
I j  h as s h o w n  t o  b e  
e ffe c t iv e .
• | n e e r p e  r a t in g  ( j n e f  " T h e r a p y  in
c o n ju n c t io n  w ith  ^ as
sh o w  n t o  b e  e .  e n  m ore 
b e n e f ic ia l in re lie vin g  s y m p to m s  
o f  c c m p i-c a t e c  g r e f .
• 3 - ’p p erC  g r o u p s .
